Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Hepatology

• Publication date

  1993-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.1840180216PMID 8393423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.

  2008cited by this paper
• DNA clonal heterogeneity of hepatocellular carcinoma demonstrated by Feulgen-DNA analysis.

  2008cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC)

  1992cited by this paper
• Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.

  1992cited by this paper
• The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound‐guided fine‐needle biopsy with those of autopsy

  1992cited by this paper
• Flow cytometric dna analysis of hepatocellular carcinoma

  1991influential reference
• Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

  1991cited by this paper
• Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

  1991cited by this paper
• Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis.

  1991cited by this paper
• Heterogeneity of Proliferative Activity in Nodule‐in‐Nodule Lesions of Small Hepatocellular Carcinoma

  1990cited by this paper
• Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice

  1987cited by this paper
• A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma

  1986cited by this paper
• Mechanisms of tumor progression.

  1986cited by this paper
• Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium.

  1985cited by this paper
• Hormonal Control of α-Fetoprotein Secretion in Human Hepatoma Cell Lines Proliferating in Chemically Defined Medium

  1985cited by this paper
• A rapid banding technique for human chromosomes.

  1971cited by this paper

• Autoimmune liver diseases in Latin America: Current landscape and challenges

  2025influential citation
• Genetic Analyses of Primary Liver Cancer Cell Lines: Correspondence With Morphological Features of Original Tumors

  2024cites this paper
• M2BPgs-HCC: An Automated Multilectin Bead Array Indicating Aberrant Glycosylation Signatures Toward Hepatitis C Virus-Associated Hepatocellular Carcinoma Prognosis

  2024cites this paper
• Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments

  2021cites this paper
• Quercetin Suppresses Proliferation of Liver Cancer Cell Lines In Vitro

  2020cites this paper
• Glycogene Expression Profiling of Hepatic Cells by RNA-Seq Analysis for Glyco-Biomarker Identification

  2020cites this paper
• Antiproliferative Effect of Lenvatinib on Human Liver Cancer Cell Lines In Vitro and In Vivo

  2019cites this paper
• High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine

  2018influential citation
• Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line

  2017cites this paper
• Long-Lived Epidermal Cancer-Initiating Cells

  2017cites this paper
• Antiproliferative effect of ME3738, a derivative of soyasapogenol, on hepatocellular carcinoma cell lines in vitro and in vivo.

  2016cites this paper
• Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma

  2016cites this paper
• Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma

  2016influential citation
• CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

  2014cites this paper
• CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging Aspects 1

  2014cites this paper
• Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells

  2014cites this paper
• The SxxSS motif of T-cell factor-4 isoforms modulates Wnt/β-catenin signal activation in hepatocellular carcinoma cells.

  2013cites this paper
• Pegylated Interferon-α2a Inhibits Proliferation of Human Liver Cancer Cells In Vitro and In Vivo

  2013cites this paper
• Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-α2a for liver cancer therapy.

  2013cites this paper
• Loss of exon 4 in a human T‐cell factor‐4 isoform promotes hepatic tumourigenicity

  2013cites this paper
• Antiproliferative effects of sorafenib and pegylated IFN-α2b on human liver cancer cells in vitro and in vivo

  2013cites this paper
• Upregulation of T‐cell factor‐4 isoform‐responsive target genes in hepatocellular carcinoma

  2013cites this paper
• Branched Chain Amino Acid Suppresses Hepatocellular Cancer Stem Cells through the Activation of Mammalian Target of Rapamycin

  2013cites this paper
• Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice

  2012influential citation
• Loss of the SxxSS Motif in a Human T-Cell Factor-4 Isoform Confers Hypoxia Resistance to Liver Cancer: An Oncogenic Switch in Wnt Signaling

  2012influential citation
• Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor‐κB/hypoxia‐inducible factor‐1α axis under hypoxic conditions

  2012cites this paper
• Stem Cells and Liver Cancer

  2011cites this paper
• N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.

  2011cites this paper
• RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.

  2010cites this paper
• Retinoblastoma in a 37 years old man in Nepal: a case report.

  2010cites this paper
• Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-α

  2010cites this paper
• Hypervascular Focus in the Nonhypervascular Nodule ("Nodule-in-Nodule") on Dynamic Computed Tomography: Imaging Evidence of Aggressive Progression in Hepatocellular Carcinoma

  2009cites this paper
• Fucoidan, a major component of brown seaweed, prohibits the growth of human cancer cell lines in vitro.

  2008cites this paper
• Switching in discoid domain receptor expressions in SLUG‐induced epithelial‐mesenchymal transition

  2008influential citation
• 原発性肝癌 肝癌の発生・進展とインターフェロンによる制御

  2008cites this paper
• Inhibitory Function of Interferon on Hepatocarcinogenesis

  2008cites this paper
• The relationship between tumor cell differentiation and age at diagnosis in retinoblastoma.

  2008cites this paper
• Growth Inhibitory Effects of IFN-β on Human Liver Cancer Cells In Vitro and In Vivo

  2007cites this paper
• Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells

  2007cites this paper
• Effects of IFN-alpha on alpha-fetoprotein expressions in hepatocellular carcinoma cells.

  2007cites this paper
• Growth inhibitory effects of IFN-beta on human liver cancer cells in vitro and in vivo.

  2007cites this paper
• Effects of IFN-α on α-Fetoprotein Expressions in Hepatocellular Carcinoma Cells

  2007cites this paper
• Growth inhibitory effects of pegylated IFN α‐2b on human liver cancer cells in vitro and in vivo

  2006cites this paper
• Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.

  2006cites this paper
• Growth inhibitory effects of interferon‐α subtypes vary according to human liver cancer cell lines

  2006cites this paper
• Antiproliferative effects of 5‐fluorouracil and interferon‐alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo

  2006cites this paper
• Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.

  2006cites this paper
• The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.

  2006cites this paper
• High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma

  2006cites this paper
• Pathology of Hepatocellular Carcinoma

  2006cites this paper
• Early Hepatocellular Carcinoma and Dysplastic Nodules

  2005cites this paper
• Expression and activation of apoptosis-related molecules involved in interferon-alpha-mediated apoptosis in human liver cancer cells.

  2005cites this paper
• Intratumoral DNA stem-line heterogeneity in superficial spreading melanoma.

  2005cites this paper
• Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.

  2005cites this paper
• Early hepatocellular carcinoma and dysplastic nodules.

  2005cites this paper
• Histopathology of liver cancers.

  2005cites this paper
• Interferon-αCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo

  2004cites this paper
• Morphological Changes of Early Human Hepatocarcinogenesis

  2004cites this paper
• Morphological changes of early human hepatocarcinogenesis.

  2004cites this paper
• ‘Nodule-in-Nodule’ Appearance in Hepatocellular Carcinoma: Its Significance as a Morphologic Marker of Dedifferentiation

  2004cites this paper
• Dedifferentiation and Proliferation of Hepatocellular Carcinoma: From Early to Advanced

  2004cites this paper
• Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo.

  2004cites this paper
• Troglitazone induces p27Kip1‐associated cell‐cycle arrest through down‐regulating Skp2 in human hepatoma cells

  2003cites this paper
• Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process.

  2002cites this paper
• The evolution of pathologic features of hepatocellular carcinoma

  2002cites this paper
• Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.

  2002cites this paper
• Pathological Evolution of Early Hepatocellular Carcinoma

  2002cites this paper
• β ‐Catenin expression in hepatocellular carcinoma: A possible participation of β ‐catenin in the dedifferentiation process

  2002cites this paper
• Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

  2001cites this paper
• Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential.

  2001cites this paper
• Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.

  2001cites this paper
• Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.

  2001cites this paper
• Expression and function of interleukin-8 in human hepatocellular carcinoma.

  2001cites this paper
• Interferon‐α delays S‐phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin‐dependent kinases

  2001cites this paper
• Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone‐induced cell‐cycle arrest in human hepatoma cell lines

  2001cites this paper
• Expression of Hu-IFN-alphaR2 chain of type I interferon receptor in human hepatocellular carcinoma and non-cancerous tissues.

  2000cites this paper
• Dedifferentiation of human hepatocellular carcinoma up-regulates telomerase and Ki-67 expression.

  2000influential citation
• Involvement of P21WAF1/CIP1 and P27KIP1 in troglitazone-induced cell cycle arrest in human hepatoma cell lines

  2000cites this paper
• Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

  1999cites this paper
• Establishment and characterization of a new human hepatocellular carcinoma cell line, HAK-3, and its response to growth factors.

  1999cites this paper
• Evolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting

  1999cites this paper
• Histopathologic Evaluation of Hepatocellular Carcinoma with Special Reference to Small Early Stage Tumors

  1999cites this paper
• Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation.

  1999cites this paper
• Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation

  1999cites this paper
• Surgical treatment for multicentric hepatocellular carcinomas according to clonality

  1998cites this paper
• Pathology of early hepatocellular carcinoma: progression from early to advanced.

  1998cites this paper
• Expression of vascular endothelial growth factor in human hepatocellular carcinoma

  1998cites this paper
• Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma

  1997cites this paper
• Deletion type hepatocyte growth factor has different effects on growth and c-met expression in 10 different human hepatocellular carcinoma cell lines.

  1997cites this paper
• Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines.

  1996cites this paper
• Cytogenetic analysis of BC2, a new human hepatoma cell line, by fluorescent in situ hybridization.

  1996cites this paper
• Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines

  1996cites this paper
• Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: Physiological basis and pathophysiological changes in cholestatic liver dysfunction *

  1996cites this paper
• Pathology of early hepatocellular carcinoma: progression from early to advanced.

  1996cites this paper
• A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.

  1996cites this paper
• Establishment of a human hepatic adenosquamous carcinoma cell line (KMC‐2) and its response to cytokines

  1995cites this paper
• Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor.

  1995cites this paper
• Expression of CD44 in human hepatocellular carcinoma cell lines

  1995cites this paper
• Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to small hepatocellular carcinoma with indistinct margins

  1995cites this paper
• Expression of intercellular adhesion molecule 1 in human hepatocellular carcinoma

  1995cites this paper